Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 1351 to 1375 of 2013

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunctionHTG402
Mechanical clot retrieval for treating acute ischaemic strokeHTG403
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem deathHTG404
Nivolumab for treating advanced (unresectable or metastatic) melanomaTA384
Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits)HTG401
Major trauma: assessment and initial managementNG39
Major trauma: service deliveryNG40
Spinal injury: assessment and initial managementNG41
Fractures (non-complex): assessment and managementNG38
Sunlight exposure: risks and benefitsNG34
Skin cancer preventionPH32
TNF-alpha inhibitors for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritisTA383
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapyTA378
Nintedanib for treating idiopathic pulmonary fibrosisTA379
Panobinostat for treating multiple myeloma after at least 2 previous treatmentsTA380
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)TA382
Percutaneous coblation of the intervertebral disc for low back pain and sciaticaHTG397
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciaticaHTG398
Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back painHTG399
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failedTA375
Guidance on the use of imatinib for chronic myeloid leukaemiaTA70
Older people: independence and mental wellbeingNG32
Care of dying adults in the last days of lifeNG31
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapyTA374

Results per page

  1. 10
  2. 25
  3. 50
  4. All